2021 Q4 Form 10-K Financial Statement

#000155837022001947 Filed on February 24, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021 Q2
Revenue $58.94M $53.86M $48.87M
YoY Change 58.91% 56.89% 100.72%
Cost Of Revenue $1.826M $1.365M $482.0K
YoY Change 79.02% -53.25% 17.56%
Gross Profit $57.12M $52.49M $48.39M
YoY Change 58.35% 67.12% 102.19%
Gross Profit Margin 96.9% 97.47% 99.01%
Selling, General & Admin $6.450M $5.307M $5.604M
YoY Change 43.65% 58.89% 86.18%
% of Gross Profit 11.29% 10.11% 11.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $12.21M $10.89M $9.841M
YoY Change 39.87% 42.44% 45.88%
% of Gross Profit 21.37% 20.75% 20.34%
Operating Expenses $18.65M $17.56M $15.93M
YoY Change 31.08% 26.32% 56.61%
Operating Profit $38.46M $36.29M $32.94M
YoY Change 68.24% 77.71% 132.36%
Interest Expense -$6.140M $6.309M $3.692M
YoY Change -429.05% 239.01% 99.03%
% of Operating Profit -15.96% 17.38% 11.21%
Other Income/Expense, Net
YoY Change
Pretax Income $28.63M $30.09M $29.34M
YoY Change 34.22% 56.58% 120.43%
Income Tax
% Of Pretax Income
Net Earnings $28.63M $30.09M $29.34M
YoY Change 34.21% 56.62% 120.43%
Net Earnings / Revenue 48.57% 55.88% 60.04%
Basic Earnings Per Share $1.24 $1.21
Diluted Earnings Per Share $1.090M $1.20 $1.17
COMMON SHARES
Basic Shares Outstanding 23.93M 23.89M 23.89M
Diluted Shares Outstanding 26.26M 26.17M

Balance Sheet

Concept 2021 Q4 2021 Q3 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $81.10M $127.3M $156.3M
YoY Change -35.64% -20.98% 211.38%
Cash & Equivalents $81.10M $127.3M $156.3M
Short-Term Investments
Other Short-Term Assets $9.996M $1.457M
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $91.09M $127.3M $157.8M
YoY Change -27.7% -20.98% 214.28%
LONG-TERM ASSETS
Property, Plant & Equipment $1.641B $1.402B $1.278B
YoY Change 60.75% 58.19% 61.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $324.9M $554.4M $649.4M
YoY Change -47.54% 22.88% 100.85%
Other Assets $5.323M
YoY Change
Total Long-Term Assets $1.994B $1.975B $1.933B
YoY Change 21.4% 47.51% 71.23%
TOTAL ASSETS
Total Short-Term Assets $91.09M $127.3M $157.8M
Total Long-Term Assets $1.994B $1.975B $1.933B
Total Assets $2.085B $2.102B $2.091B
YoY Change 17.9% 40.15% 77.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.353M $8.224M $3.265M
YoY Change 145.1% 647.64% 104.06%
Accrued Expenses $1.532M $1.633M $4.791M
YoY Change -43.26% 25.62% 77.44%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $146.8M $159.1M $144.5M
YoY Change 37.98% 69.95% 96.86%
LONG-TERM LIABILITIES
Long-Term Debt $326.1M $431.9M $431.2M
YoY Change 138.55% 217.09% 217.75%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $326.1M $431.9M $431.2M
YoY Change 138.55% 217.09% 217.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $146.8M $159.1M $144.5M
Total Long-Term Liabilities $326.1M $431.9M $431.2M
Total Liabilities $472.9M $591.0M $575.7M
YoY Change 94.52% 157.1% 175.21%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $1.673B $1.562B $1.560B
YoY Change 7.3% 20.59% 57.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.612B $1.511B $1.515B
YoY Change
Total Liabilities & Shareholders Equity $2.085B $2.102B $2.091B
YoY Change 17.9% 40.15% 77.32%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021 Q2
OPERATING ACTIVITIES
Net Income $28.63M $30.09M $29.34M
YoY Change 34.21% 56.62% 120.43%
Depreciation, Depletion And Amortization $12.21M $10.89M $9.841M
YoY Change 39.87% 42.44% 45.88%
Cash From Operating Activities $47.79M $51.57M $46.79M
YoY Change 39.73% 53.93% 99.11%
INVESTING ACTIVITIES
Capital Expenditures -$277.1M -$133.9M -$158.5M
YoY Change 101.08% 43.53% 10.32%
Acquisitions
YoY Change
Other Investing Activities $226.5M $87.59M -$115.5M
YoY Change -234.8% -169.02% 135.29%
Cash From Investing Activities -$50.62M -$46.32M -$274.2M
YoY Change -83.45% -78.97% 42.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -38.05M -34.26M 261.5M
YoY Change -116.09% -111.97% 162.52%
NET CHANGE
Cash From Operating Activities 47.79M 51.57M 46.79M
Cash From Investing Activities -50.62M -46.32M -274.2M
Cash From Financing Activities -38.05M -34.26M 261.5M
Net Change In Cash -40.88M -29.02M 34.11M
YoY Change 16.46% -129.19% -149.01%
FREE CASH FLOW
Cash From Operating Activities $47.79M $51.57M $46.79M
Capital Expenditures -$277.1M -$133.9M -$158.5M
Free Cash Flow $324.9M $185.5M $205.3M
YoY Change 88.88% 46.28% 22.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001677576
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23936928
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25612541
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25612541
CY2021Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-37949
CY2021 dei Entity Registrant Name
EntityRegistrantName
Innovative Industrial Properties, Inc.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2963381
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
1389 Center Drive, Suite 200
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Park City
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84098
CY2021 dei City Area Code
CityAreaCode
858
CY2021 dei Local Phone Number
LocalPhoneNumber
997-3332
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
40195000
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1640166000
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1020044000
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
4500000000
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25624772
CY2021 dei Auditor Name
AuditorName
BDO USA, LLP
CY2021 dei Auditor Location
AuditorLocation
San Diego, California
CY2021 dei Auditor Firm
AuditorFirmId
243
CY2021Q4 us-gaap Land
Land
122386000
CY2020Q4 us-gaap Land
Land
75660000
CY2021Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
979417000
CY2020Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
644932000
CY2021Q4 us-gaap Tenant Improvements
TenantImprovements
620301000
CY2020Q4 us-gaap Tenant Improvements
TenantImprovements
339647000
CY2021Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1722104000
CY2020Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1060239000
CY2021Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
81938000
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
12916000
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
0
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81096000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
126006000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
5323000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
0
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
324889000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
619275000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1068000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
980000
CY2021Q4 us-gaap Finite Lived Intangible Asset Acquired In Place Leases
FiniteLivedIntangibleAssetAcquiredInPlaceLeases
9148000
CY2020Q4 us-gaap Finite Lived Intangible Asset Acquired In Place Leases
FiniteLivedIntangibleAssetAcquiredInPlaceLeases
0
CY2021Q4 us-gaap Other Assets
OtherAssets
9996000
CY2020Q4 us-gaap Other Assets
OtherAssets
1776000
CY2021Q4 us-gaap Assets
Assets
2084602000
CY2020Q4 us-gaap Assets
Assets
1768081000
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
32232000
CY2020Q4 us-gaap Convertible Debt
ConvertibleDebt
136693000
CY2021Q4 us-gaap Unsecured Debt
UnsecuredDebt
293860000
CY2020Q4 us-gaap Unsecured Debt
UnsecuredDebt
0
CY2021Q4 iipr Tenant Improvements And Construction Payable
TenantImprovementsAndConstructionPayable
46274000
CY2020Q4 iipr Tenant Improvements And Construction Payable
TenantImprovementsAndConstructionPayable
36500000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
7718000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
4641000
CY2021Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
38847000
CY2020Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
30065000
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
1167000
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
1057000
CY2021Q4 iipr Rents Received In Advance And Tenant Security Deposit
RentsReceivedInAdvanceAndTenantSecurityDeposit
52805000
CY2020Q4 iipr Rents Received In Advance And Tenant Security Deposit
RentsReceivedInAdvanceAndTenantSecurityDeposit
34153000
CY2021Q4 us-gaap Liabilities
Liabilities
472903000
CY2020Q4 us-gaap Liabilities
Liabilities
243109000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
14009000
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
14009000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25612541
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23936928
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
26000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
24000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1672882000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1559059000
CY2021Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
75218000
CY2020Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
48120000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1611699000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1524972000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2084602000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1768081000
CY2021 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
204551000
CY2020 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
116896000
CY2019 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
44667000
CY2021 us-gaap Revenues
Revenues
204551000
CY2020 us-gaap Revenues
Revenues
116896000
CY2019 us-gaap Revenues
Revenues
44667000
CY2021 us-gaap Lease Cost
LeaseCost
4443000
CY2020 us-gaap Lease Cost
LeaseCost
4952000
CY2019 us-gaap Lease Cost
LeaseCost
1315000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22961000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14182000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9818000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41776000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28025000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8599000
CY2021 us-gaap Operating Expenses
OperatingExpenses
69180000
CY2020 us-gaap Operating Expenses
OperatingExpenses
47159000
CY2019 us-gaap Operating Expenses
OperatingExpenses
19732000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
135371000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
69737000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
24935000
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
397000
CY2020 us-gaap Interest And Other Income
InterestAndOtherIncome
3424000
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
139736000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3384000
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
8616000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1611699000
CY2021 us-gaap Profit Loss
ProfitLoss
113990000
CY2019 us-gaap Interest And Other Income
InterestAndOtherIncome
4846000
CY2021 us-gaap Interest Expense
InterestExpense
18086000
CY2020 us-gaap Interest Expense
InterestExpense
7431000
CY2019 us-gaap Interest Expense
InterestExpense
6306000
CY2021 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
3692000
CY2020 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0
CY2019 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0
CY2021 us-gaap Net Income Loss
NetIncomeLoss
113990000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
65730000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
23475000
CY2021 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1352000
CY2020 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1352000
CY2019 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1352000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
112638000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
64378000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22123000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.69
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.28
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.06
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.55
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.27
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.03
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23903017
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19443602
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10546016
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26261155
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19557619
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10684068
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
264292000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
23475000
CY2019 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
5569000
CY2019 iipr Stock Issued During Period Value Sale Of Common Stock
StockIssuedDuringPeriodValueSaleOfCommonStock
286270000
CY2019 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1352000
CY2019 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
31800000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-939000
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
2495000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
548010000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
65730000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1000
CY2020 iipr Stock Issued During Period Value Sale Of Common Stock
StockIssuedDuringPeriodValueSaleOfCommonStock
1003973000
CY2020 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1352000
CY2020 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
92554000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-2166000
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
3330000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1524972000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
113990000
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
108593000
CY2021 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1352000
CY2020 iipr Amortization Of Discounts On Short Term Investments
AmortizationOfDiscountsOnShortTermInvestments
-2791000
CY2019 iipr Amortization Of Discounts On Short Term Investments
AmortizationOfDiscountsOnShortTermInvestments
-3738000
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1678000
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2851000
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2040000
CY2020 us-gaap Profit Loss
ProfitLoss
65730000
CY2019 us-gaap Profit Loss
ProfitLoss
23475000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41776000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28025000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8599000
CY2021 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
3692000
CY2019 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-95000
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-162000
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
8616000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
3330000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
2495000
CY2021 iipr Amortization Of Discounts On Short Term Investments
AmortizationOfDiscountsOnShortTermInvestments
-340000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3687000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
428000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
619000
CY2021 iipr Increase Decrease In Accounts Payable Accrued Liabilities And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLiabilities
3102000
CY2020 iipr Increase Decrease In Accounts Payable Accrued Liabilities And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLiabilities
1224000
CY2019 iipr Increase Decrease In Accounts Payable Accrued Liabilities And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLiabilities
1427000
CY2021 iipr Increase Decrease In Rents Received In Advance And Tenant Security Deposit
IncreaseDecreaseInRentsReceivedInAdvanceAndTenantSecurityDeposit
18652000
CY2020 iipr Increase Decrease In Rents Received In Advance And Tenant Security Deposit
IncreaseDecreaseInRentsReceivedInAdvanceAndTenantSecurityDeposit
13522000
CY2019 iipr Increase Decrease In Rents Received In Advance And Tenant Security Deposit
IncreaseDecreaseInRentsReceivedInAdvanceAndTenantSecurityDeposit
11617000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
188747000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
110814000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
44934000
CY2021 us-gaap Payments To Acquire Real Estate Held For Investment
PaymentsToAcquireRealEstateHeldForInvestment
287585000
CY2020 us-gaap Payments To Acquire Real Estate Held For Investment
PaymentsToAcquireRealEstateHeldForInvestment
240509000
CY2019 us-gaap Payments To Acquire Real Estate Held For Investment
PaymentsToAcquireRealEstateHeldForInvestment
259889000
CY2021 us-gaap Payments For Tenant Improvements
PaymentsForTenantImprovements
374541000
CY2020 us-gaap Payments For Tenant Improvements
PaymentsForTenantImprovements
289517000
CY2019 us-gaap Payments For Tenant Improvements
PaymentsForTenantImprovements
84677000
CY2021 iipr Funding Of Construction Loan And Other Investments
FundingOfConstructionLoanAndOtherInvestments
16068000
CY2019 iipr Funding Of Construction Loan And Other Investments
FundingOfConstructionLoanAndOtherInvestments
0
CY2021 iipr Payment Of Deposits To Escrow For Acquisition
PaymentOfDepositsToEscrowForAcquisition
625000
CY2020 iipr Payment Of Deposits To Escrow For Acquisition
PaymentOfDepositsToEscrowForAcquisition
200000
CY2019 iipr Payment Of Deposits To Escrow For Acquisition
PaymentOfDepositsToEscrowForAcquisition
650000
CY2021 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
569772000
CY2020 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1077867000
CY2019 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
255664000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
864498000
CY2020 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
580978000
CY2019 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
260250000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-384093000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1027115000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-340630000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1003973000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
286292000
CY2019 iipr Proceeds From Issuance Of Exchange Of Senior Notes
ProceedsFromIssuanceOfExchangeOfSeniorNotes
138545000
CY2021 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
300000000
CY2019 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
0
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
6855000
CY2019 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
CY2021 iipr Payment Of Inducement And Transaction Costs Relating To Inducement Of Debt
PaymentOfInducementAndTransactionCostsRelatingToInducementOfDebt
1696000
CY2019 iipr Payment Of Inducement And Transaction Costs Relating To Inducement Of Debt
PaymentOfInducementAndTransactionCostsRelatingToInducementOfDebt
0
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
130954000
CY2020 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
75464000
CY2019 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
22584000
CY2021 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1352000
CY2020 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1352000
CY2019 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1352000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3384000
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2166000
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
939000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
155759000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
924991000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
399962000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-39587000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8690000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
104266000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126006000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117316000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13050000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86419000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126006000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117316000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
14381000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
5391000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
3055000
CY2021 iipr Accrual For Reimbursements Of Tenant Improvements And Construction Funding
AccrualForReimbursementsOfTenantImprovementsAndConstructionFunding
46274000
CY2020 iipr Accrual For Reimbursements Of Tenant Improvements And Construction Funding
AccrualForReimbursementsOfTenantImprovementsAndConstructionFunding
36500000
CY2019 iipr Accrual For Reimbursements Of Tenant Improvements And Construction Funding
AccrualForReimbursementsOfTenantImprovementsAndConstructionFunding
24968000
CY2021 us-gaap Escrow Deposit Disbursements Related To Property Acquisition1
EscrowDepositDisbursementsRelatedToPropertyAcquisition1
200000
CY2020 us-gaap Escrow Deposit Disbursements Related To Property Acquisition1
EscrowDepositDisbursementsRelatedToPropertyAcquisition1
650000
CY2019 us-gaap Escrow Deposit Disbursements Related To Property Acquisition1
EscrowDepositDisbursementsRelatedToPropertyAcquisition1
0
CY2021 iipr Accrual For Common And Preferred Stock Dividends Declared
AccrualForCommonAndPreferredStockDividendsDeclared
38847000
CY2020 iipr Accrual For Common And Preferred Stock Dividends Declared
AccrualForCommonAndPreferredStockDividendsDeclared
30065000
CY2019 iipr Accrual For Common And Preferred Stock Dividends Declared
AccrualForCommonAndPreferredStockDividendsDeclared
12975000
CY2019 iipr Invoices Accrued For Offering Cost
InvoicesAccruedForOfferingCost
22000
CY2021 iipr Exchange Of Senior Notes
ExchangeOfSeniorNotes
109040000
CY2019 iipr Exchange Of Senior Notes
ExchangeOfSeniorNotes
1000
CY2021 iipr Operating Lease Liability For Obtaining Right Of Use Asset
OperatingLeaseLiabilityForObtainingRightOfUseAsset
192000
CY2019 iipr Operating Lease Liability For Obtaining Right Of Use Asset
OperatingLeaseLiabilityForObtainingRightOfUseAsset
1211000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of Estimates. </b>The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make a number of estimates and assumptions that affect the reported amounts and disclosures in the consolidated financial statements. Actual results may differ materially from these estimates and assumptions.</p>
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021 us-gaap Depreciation
Depreciation
41700000
CY2020 us-gaap Depreciation
Depreciation
28000000.0
CY2019 us-gaap Depreciation
Depreciation
8600000
CY2021 us-gaap Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Provision for Impairment. </b>We review current activities and changes in the business conditions of all of our properties to determine the existence of any triggering events or impairment indicators requiring an impairment analysis. If triggering events or impairment indicators are identified, we review an estimate of the future undiscounted cash flows for the properties, including, if necessary, a probability-weighted approach if multiple outcomes are under consideration.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Long-lived assets are individually evaluated for impairment when conditions exist that may indicate that the carrying amount of a long-lived asset may not be recoverable. The carrying amount of a long-lived asset to be held and used is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. Impairment indicators or triggering events for long-lived assets to be held and used are assessed by project and include significant fluctuations in estimated net operating income, occupancy changes, significant near-term lease expirations, current and historical operating and/or cash flow losses, construction costs, estimated completion </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">dates, rental rates, and other market factors. We assess the expected undiscounted cash flows based upon numerous factors, including, but not limited to, construction costs, available market information, current and historical operating results, known trends, current market/economic conditions that may affect the property, and our assumptions about the use of the asset, including, if necessary, a probability-weighted approach if multiple outcomes are under consideration. Upon determination that an impairment has occurred, a write-down is recognized to reduce the carrying amount to its estimated fair value. We may adjust depreciation of properties that are expected to be disposed of or redeveloped prior to the end of their useful lives. No impairment losses were recognized during the years ended December 31, 2021, 2020 and 2019.</p>
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021Q2 iipr Construction Loan Maximum Capacity
ConstructionLoanMaximumCapacity
18500000
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
12900000
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
72000000.0
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
98300000
CY2019Q1 us-gaap Lease Practical Expedients Package
LeasePracticalExpedientsPackage
true
CY2018Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0725
CY2021Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.055
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
234000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
172000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
87000
CY2020 iipr Number Of Affected Tenants Granted Deferrals
NumberOfAffectedTenantsGrantedDeferrals
3
CY2020 iipr Number Of Affected Tenants Granted Deferrals
NumberOfAffectedTenantsGrantedDeferrals
3
CY2020 iipr Number Of Affected Tenants Security Deposits Applied To Portion Of Base Rent
NumberOfAffectedTenantsSecurityDepositsAppliedToPortionOfBaseRent
1
CY2020Q3 iipr Period Of Repayment Of Security Deposit And Deferred Rent
PeriodOfRepaymentOfSecurityDepositAndDeferredRent
P18M
CY2020Q2 iipr Security Deposit Applied For Payment Of Rent
SecurityDepositAppliedForPaymentOfRent
940000
CY2020Q1 iipr Repayments Of Base Rent And Property Management Fee
RepaymentsOfBaseRentAndPropertyManagementFee
185000
CY2020 iipr Number Of Affected Tenants Security Deposits Applied To Portion Of Base Rent
NumberOfAffectedTenantsSecurityDepositsAppliedToPortionOfBaseRent
1
CY2020Q2 iipr Base Rent Deferrals
BaseRentDeferrals
1500000
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Concentration of Credit Risk</b>. As of December 31, 2021, we owned 103 properties located in Arizona, California, Colorado, Florida, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nevada, New Jersey, New York, North Dakota, Ohio, Pennsylvania, Texas, Virginia, and Washington. The ability of any of our tenants to honor the terms of its lease is dependent upon the economic, regulatory, competition, natural and social factors affecting the community in which that tenant operates. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Two of our tenants, PharmaCann Inc. (“PharmaCann”) (at five of our properties) and SH Parent Inc. (“Parallel”) (at four of our properties), represented approximately 12% and 10%, respectively, of our rental revenue (including tenant reimbursements) for the year ended December 31, 2021. Three of our tenants, PharmaCann (at five of our properties), Ascend Wellness Holdings, Inc. (“Ascend”) (at three of our properties), and Cresco Labs Inc. (“Cresco”) (at five of our properties), represented approximately 18%, 10%, and 10%, respectively, of our rental revenues (including tenant reimbursements) for the year ended December 31, 2020. Two of our tenants, PharmaCann (at five of our properties) and Ascend (at two of our properties), represented approximately 26% and 12%, respectively, of our rental revenues (including tenant reimbursements) for the year ended December 31, 2019. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At December 31, 2021 and 2020, none of our properties individually represented more than 5%<span style="white-space:pre-wrap;"> of our net real estate held for investment. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We have deposited cash with a financial institution that is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of December 31, 2021, we had cash accounts in excess of FDIC insured limits. We have not experienced any losses in such accounts.</p>
CY2021Q4 iipr Number Of Properties
NumberOfProperties
103
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25612541
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2019Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4412000
CY2019Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5625
CY2019Q2 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
338000
CY2019Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.60
CY2019Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5885000
CY2019Q2 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5625
CY2019Q3 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
338000
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.78
CY2019Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8866000
CY2019Q3 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5625
CY2019Q4 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
338000
CY2019Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.00
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12637000
CY2019Q4 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5625
CY2020Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
338000
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.00
CY2020Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
17070000
CY2020Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5625
CY2020Q2 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
338000
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.06
CY2020Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
19770000
CY2020Q2 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5625
CY2020Q3 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
338000
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.17
CY2020Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
25987000
CY2020Q3 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5625
CY2020Q4 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
338000
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.24
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
29727000
CY2020Q4 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5625
CY2021Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
338000
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.32
CY2021Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
31660000
CY2021Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5625
CY2021Q2 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
338000
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.40
CY2021Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
33584000
CY2021Q2 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5625
CY2021Q3 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
338000
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.50
CY2021Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
35983000
CY2021Q3 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5625
CY2021Q4 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
338000
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.50
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
38509000
CY2021Q4 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5625
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
338000
CY2021Q4 us-gaap Net Rentable Area
NetRentableArea
2272000
CY2021Q4 iipr Real Estate Investment Purchase Price
RealEstateInvestmentPurchasePrice
287653000
CY2021 iipr Real Estate Investments Transaction Costs
RealEstateInvestmentsTransactionCosts
299000
CY2021Q4 us-gaap Real Estate Investments
RealEstateInvestments
287952000
CY2021Q4 iipr Rentable Area Excluded
RentableAreaExcluded
110000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33000
CY2021 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P11Y8M12D
CY2021Q4 iipr Real Estate Property Cost
RealEstatePropertyCost
384100000
CY2021Q4 iipr Reimbursement Payable For Acquisition Of Real Estate And Tenant Improvement
ReimbursementPayableForAcquisitionOfRealEstateAndTenantImprovement
374500000
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
258705000
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
272576000
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
280595000
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
288955000
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
297597000
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
4237164000
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
5635592000
CY2021Q4 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
3700000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
33373000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
300000000
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
333373000
CY2021 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
2180550
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2158837
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2100307
CY2021 us-gaap Net Income Loss
NetIncomeLoss
113990000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
65730000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
23475000
CY2021 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1352000
CY2020 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1352000
CY2019 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1352000
CY2021 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
557000
CY2020 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
509000
CY2019 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
396000
CY2021 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
112081000
CY2020 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
63869000
CY2019 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
21727000
CY2021 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
7517000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
119598000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
63869000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
21727000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23903017
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19443602
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10546016
CY2021 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
2180550
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26261155
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19557619
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10684068
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.69
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.28
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.06
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.55
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.27
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.03
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
324889000
CY2021Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
324772000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
619275000
CY2020Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
619270000
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
32232000
CY2021Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
134270000
CY2020Q4 us-gaap Convertible Debt
ConvertibleDebt
136693000
CY2020Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
397663000
CY2021Q4 us-gaap Unsecured Debt
UnsecuredDebt
293860000
CY2021Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
318486000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
241000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
249000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
256000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
264000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
295000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1305000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
163000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1142000
CY2021Q4 us-gaap Real Estate And Accumulated Depreciation Initial Cost Of Land
RealEstateAndAccumulatedDepreciationInitialCostOfLand
122386000
CY2021Q4 us-gaap Real Estate And Accumulated Depreciation Initial Cost Of Buildings And Improvements
RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
733737000
CY2021Q4 us-gaap Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Carrying Costs
RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionCarryingCosts
865981000
CY2021Q4 us-gaap Real Estate And Accumulated Depreciation Carrying Amount Of Land
RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
122386000
CY2021Q4 us-gaap Real Estate And Accumulated Depreciation Carrying Amount Of Buildings And Improvements
RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
1599718000
CY2021Q4 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
1722104000
CY2021Q4 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
81938000
CY2021Q4 us-gaap Sec Schedule Iii Real Estate Investment Property Net
SECScheduleIIIRealEstateInvestmentPropertyNet
1640166000
CY2020Q4 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
1060239000
CY2019Q4 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
518031000
CY2018Q4 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
150930000
CY2021 us-gaap Real Estate Other Acquisitions
RealEstateOtherAcquisitions
277717000
CY2020 us-gaap Real Estate Other Acquisitions
RealEstateOtherAcquisitions
241159000
CY2019 us-gaap Real Estate Other Acquisitions
RealEstateOtherAcquisitions
259889000
CY2021 us-gaap Real Estate Improvements
RealEstateImprovements
384148000
CY2020 us-gaap Real Estate Improvements
RealEstateImprovements
301049000
CY2019 us-gaap Real Estate Improvements
RealEstateImprovements
107212000
CY2021Q4 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
1722104000
CY2020Q4 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
1060239000
CY2019Q4 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
518031000
CY2020Q4 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
40195000
CY2019Q4 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
12170000
CY2018Q4 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
3571000
CY2021 us-gaap Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense
SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense
41743000
CY2020 us-gaap Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense
SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense
28025000
CY2019 us-gaap Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense
SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense
8599000
CY2021Q4 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
81938000
CY2020Q4 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
40195000
CY2019Q4 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
12170000

Files In Submission

Name View Source Status
0001558370-22-001947-index-headers.html Edgar Link pending
0001558370-22-001947-index.html Edgar Link pending
0001558370-22-001947.txt Edgar Link pending
0001558370-22-001947-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
iipr-20211231.xsd Edgar Link pending
iipr-20211231x10k.htm Edgar Link pending
iipr-20211231x10k005.jpg Edgar Link pending
iipr-20211231x10k_htm.xml Edgar Link completed
iipr-20211231xex21d1.htm Edgar Link pending
iipr-20211231xex23d1.htm Edgar Link pending
iipr-20211231xex31d1.htm Edgar Link pending
iipr-20211231xex31d2.htm Edgar Link pending
iipr-20211231xex32d1.htm Edgar Link pending
iipr-20211231_cal.xml Edgar Link unprocessable
iipr-20211231_def.xml Edgar Link unprocessable
iipr-20211231_lab.xml Edgar Link unprocessable
iipr-20211231_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending